Related references
Note: Only part of the references are listed.Mucositis: pathobiology and management
Alessandro Villa et al.
CURRENT OPINION IN ONCOLOGY (2015)
The role of oral flora in the development of chemotherapy-induced oral mucositis
Andrea M. Stringer et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2015)
grofit: Fitting Biological Growth Curves withR
Matthias Kahm et al.
Journal of Statistical Software (2015)
Microbiota and their role in the pathogenesis of oral mucositis
B. Vanhoecke et al.
ORAL DISEASES (2015)
Case report of bacteremia due to Neisseria mucosa
Arij Mechergui et al.
APMIS (2014)
Routine bacterial analysis with automated flow cytometry
Sam Van Nevel et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2013)
Gut microbiota and gastrointestinal health: current concepts and future directions
Q. Aziz et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2013)
Developing oral probiotics from Streptococcus salivarius
Philip A. Wescombe et al.
FUTURE MICROBIOLOGY (2012)
Incidence and risk factors for infection in oral cancer patients undergoing different treatments protocols
Manju Panghal et al.
BMC ORAL HEALTH (2012)
Escherichia coli Dihydropyrimidine Dehydrogenase Is a Novel NAD-Dependent Heterotetramer Essential for the Production of 5,6-Dihydrouracil
Ryota Hidese et al.
JOURNAL OF BACTERIOLOGY (2011)
The Human Oral Microbiome
Floyd E. Dewhirst et al.
JOURNAL OF BACTERIOLOGY (2010)
Molecular methodology to assess the impact of cancer chemotherapy on the oral bacterial flora: a pilot study
Joel J. Napenas et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY (2010)
Oral Biofilm Architecture on Natural Teeth
Vincent Zijnge et al.
PLOS ONE (2010)
Gastrointestinal Microflora and Mucins May Play a Critical Role in the Development of 5-Fluorouracil-Induced Gastrointestinal Mucositis
Andrea M. Stringer et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2009)
Pharmacokinetically Guided Dose Adjustment of 5-Fluorouracil: A Rational Approach to Improving Therapeutic Outcomes
M. Wasif Saif et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Quantitation of 5-fluorouracil (5-FU) in human plasma by liquid chromatography/electrospray ionization tandem mass spectrometry
Juliann E. Kosovec et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2008)
Assessment and interpretation of bacterial viability by using the LIVE/DEAD BacLight kit in combination with flow cytometry
Michael Berney et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2007)
Plasma concentrations of 5-fluorouracil and its metabolites in colon cancer patients
F Casale et al.
PHARMACOLOGICAL RESEARCH (2004)
5-Fluorouracil: Mechanisms of action and clinical strategies
DB Longley et al.
NATURE REVIEWS CANCER (2003)
5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development
JL Grem
INVESTIGATIONAL NEW DRUGS (2000)
Share Paper
